...
首页> 外文期刊>Malaria Journal >Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates
【24h】

Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates

机译:印度分离株恶性疟原虫裂殖子表面蛋白-1等位基因之间的多态性和表位共享

获取原文
           

摘要

Background The C-terminal region of merozoite surface protein-1 (MSP-1) is one of the leading candidates for vaccination against the erythrocytic stages of malaria. However, a major concern in the development of MSP-1 based malaria vaccine is the polymorphism observed in different geographical Plasmodium falciparum isolates. To explore whether the sequence heterogeneity of PfMSP-1 leads to variation in naturally acquired anti-MSP-119 antibodies, the present study was undertaken to study PfMSP-119 sequence polymorphism in malaria-endemic villages in eastern India and also carried out a competition enzyme-linked immunosorbent assay using three PfMSP-119 variant forms. Methods The sequence variations in the C-terminal region of PfMSP-119 were determined in a malaria endemic region. Three PfMSP-119 variants were produced in Escherichia coli (PfMSP119QKNG-L, PfMSP119EKNG-L and PfMSP119ETSR-F) and an immunodepletion assay was carried out using the corresponding patients' sera. Results Results revealed predominance of PfMAD20 allele among Indian field isolates. Seven PfMSP-119 variant forms were isolated in a singe geographical location. Three of PfMSP-119 variant forms when expressed in E. coli showed presence of cross-reaction as well as variant specific antibodies in malaria infected patient sera. Conclusion The present study demonstrates the existence of allele specific antibodies in P. falciparum-infected patient sera, however their role in protection requires further investigation. These results thereby, suggest the importance of a multi-allelic PfMSP-119 based vaccine for an effective malaria control.
机译:背景裂殖子表面蛋白1(MSP-1)的C端区域是针对疟疾的红细胞阶段进行疫苗接种的主要候选对象之一。然而,基于MSP-1的疟疾疫苗开发中的主要关注是在不同地理恶性疟原虫分离物中观察到的多态性。为了研究PfMSP-1的序列异质性是否导致自然获得的抗MSP-119抗体的变异,本研究旨在研究印度东部疟疾流行村庄的PfMSP-119序列多态性,并进行了竞争酶的研究。三种PfMSP-119变体形式的单链免疫吸附测定。方法测定疟疾流行区PfMSP-119 C末端区域的序列变异。在大肠杆菌中产生了三种PfMSP-119变体(PfMSP119QKNG-L,PfMSP119EKNG-L和PfMSP119ETSR-F),并使用相应患者的血清进行了免疫耗竭试验。结果结果显示,PfMAD20等位基因在印度田间分离株中占优势。在单一地理位置分离了七个PfMSP-119变体形式。当在大肠杆菌中表达时,三种PfMSP-119变体形式在疟疾感染的患者血清中显示出交叉反应以及变体特异性抗体的存在。结论本研究证明恶性疟原虫感染的患者血清中存在等位基因特异性抗体,但其在保护中的作用尚待进一步研究。因此,这些结果表明,基于多等位基因PfMSP-119的疫苗对于有效控制疟疾具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号